This article has Open Peer Review reports available.
Placenta previa percreta left in situ - management by delayed hysterectomy: a case report
© Tikkanen et al; licensee BioMed Central Ltd. 2011
Received: 8 March 2011
Accepted: 25 August 2011
Published: 25 August 2011
Placenta percreta is an obstetric emergency often associated with massive hemorrhage and emergency hysterectomy.
We present the case of a 30-year-old African woman, gravida 7, para 5, with placenta percreta managed by an alternative approach: the placenta was left in situ, methotrexate was administered, and a delayed hysterectomy was successfully performed.
Further studies are needed to develop the most appropriate management option for the most severe cases of abnormal placentation. Delayed hysterectomy may be a reasonable strategy in the most severe cases.
Placenta accreta (PA) is characterized by abnormal invasion of the placenta into the myometrium. PA is defined as superficial invasion, placenta increta as middle layer invasion and placenta percreta as deep invasion, which is the most severe form of PA with an incidence of one in 7000. All three types are collectively known as placenta accreta. The incidence of PA has dramatically increased due to increasing Caesarean section rates [1, 2]. Although rare, PA is one of the most severe pregnancy complications. Maternal morbidity and mortality associated with PA is mainly caused by massive obstetric hemorrhage or emergency hysterectomy, and PA is often diagnosed during delivery or immediately post-partum leading to an obstetric emergency [1, 3, 4]. Studies suggest that antenatal diagnosis may reduce obstetric hemorrhage-related morbidity [5, 6]. Furthermore, in some cases a morbidly adherent PA can be left in situ[7, 8]. Such conservative management may allow delayed removal of the placenta to avoid massive hemorrhage during an attempted forced removal of the adherent placenta. We describe a case in which placenta percreta was left in situ. Subsequent post-partum hemorrhage was successfully managed by delayed hysterectomy.
PA causes considerable maternal morbidity and mortality and is the major indication for emergency peri-partum hysterectomy. Antenatal confirmation of PA diagnosis is often difficult [3, 9, 10]. The management is usually an elective cesarean delivery and hysterectomy, but this approach often causes massive hemorrhage and may cause injury of adjacent organs due to the morbidly adherent placenta . Delayed trans-vaginal removal of the placenta has also been described . Some studies suggests that leaving placenta in situ lowers the risk for subsequent hysterectomy and may hence be an option in cases when emergency hysterectomy is considered too risky or fertility needs to be preserved [7, 8, 12].
We describe a severe case of PA histopathologically defined as placenta percreta in which the placenta was left in situ. Subsequently, our patient had multiple emergency room visits and ultimately developed severe post-partum hemorrhage leading to delayed emergency hysterectomy. This case suggests that in some cases with placenta accreta and percreta, leaving placenta in situ may be an alternative management option allowing delayed hysterectomy. This management option may be safer than primary hysterectomy since delayed hysterectomy may be easier to perform than emergency hysterectomy immediately post-partum (due to placental involution and decreased uterine vascularity). We are currently developing a management algorithm for women with an antenatal diagnosis of placenta percreta in which the placenta is left in situ, combined with parenteral methotrexate and elective delayed hysterectomy (although methotrexate is not used in all maternal-fetal centers in such clinical situations). This is justified based on our experience of other cases of placenta accreta in which the placenta was left in situ. Total placental involution with no complications occurred in only one out of five such cases with the placenta left in situ.
Placenta percreta is an obstetric emergency often associated with massive hemorrhage leading to emergency hysterectomy. We describe a severe case of placenta percreta in which the placenta was left in situ, methotrexate administered and a delayed hysterectomy successfully performed. Delayed hysterectomy may be a reasonable management strategy in the most severe cases.
Written informed consent was obtained from the patient for publication of this case report and any accompanying images. A copy of the written consent is available for review by the Editor-in-Chief of this journal.
- Belfort MA: SMFM Publication Committee: placenta accreta. Am J Obstet Gynecol. 2010, 203: 430-439. 10.1016/j.ajog.2010.09.013.View ArticlePubMedGoogle Scholar
- Wu S, Kocherginsky M, Hibbard JU: Abnormal placentation: twenty-year analysis. Am J Obstet Gynecol. 2005, 192: 1458-1461. 10.1016/j.ajog.2004.12.074.View ArticlePubMedGoogle Scholar
- Tikkanen M, Paavonen J, Loukovaara M, Stefanovic V: Antenatal diagnosis of placenta accreta leads to reduced blood loss. Acta Obstet Gynecol Scand. 2011, 10.1111/j.1600-0412.2011.01147.x..Google Scholar
- Hoffman MS, Karlnoski RA, Mangar D, Whiteman VE, Zweibel BR, Lockhart JL, Camporesi EM: Morbidity associated with nonemergent hysterectomy for placenta accreta. Am J Obstet Gynecol. 2010, 202: 628.e1-5. 10.1016/j.ajog.2010.03.021.View ArticleGoogle Scholar
- Warshak CR, Ramos GA, Eskander R, Benirschke K, Saenz CC, Kelly TF, Moore TR, Resnik R: Effect of predelivery diagnosis in 99 consecutive cases of placenta accreta. Obstet Gynecol. 2010, 115: 65-69. 10.1097/AOG.0b013e3181c4f12a.View ArticlePubMedGoogle Scholar
- Angstmann T, Gard G, Harrington T, Ward E, Thomson A, Giles W: Surgical management of placenta accreta: a cohort series and suggested approach. Am J Obstet Gynecol. 2010, 202: 38.e1-9. 10.1016/j.ajog.2009.08.037.View ArticleGoogle Scholar
- Palacios-Jaraquemada JM: Diagnosis and management of placenta accreta. Best Pract Res Clin Obstet Gynecol. 2008, 22: 1133-1148. 10.1016/j.bpobgyn.2008.08.003.View ArticleGoogle Scholar
- Sentilhes L, Ambroselli C, Kayem G, Provansal M, Fernandez H, Perrotin F, Winer N, Pierre F, Benachi A, Dreyfus M, Bauville E, Mahieu-Caputo D, Marpeau L, Descamps P, Goffinet F, Bretelle F: Maternal outcome after conservative treatment of placenta accreta. Obstet Gynecol. 2010, 115: 526-534. 10.1097/AOG.0b013e3181d066d4.View ArticlePubMedGoogle Scholar
- Warshak CR, Eskander R, Hull AD, Scioscia AL, Mattrey RF, Benirschke K, Resnik R: Accuracy of ultrasonography and magnetic resonance imaging in the diagnosis of placenta accreta. Obstet Gynecol. 2006, 108: 573-581. 10.1097/01.AOG.0000233155.62906.6d.View ArticlePubMedGoogle Scholar
- Palacios Jaraquemada JM, Bruno CH: Magnetic resonance imaging in 300 cases of placenta accreta: surgical correlation of new findings. Acta Obstet Gynecol Scand. 2005, 84: 716-724.View ArticlePubMedGoogle Scholar
- Descargues G, Clavier E, Lemercier E, Sibert L: Placenta percreta with bladder invasion managed by arterial embolization and manual removal after cesarean. Obstet Gynecol. 2000, 96 (Suppl 5): 840-PubMedGoogle Scholar
- Sentilhes L, Kayem G, Ambroselli C, Provansal M, Fernandez H, Perrotin F, Winer N, Pierre F, Benachi A, Dreyfus M, Bauville E, Mahieu-Caputo D, Marpeau L, Descamps P, Bretelle F, Goffinet F: Fertility and pregnancy outcomes following conservative treatment for placenta accreta. Hum Reprod. 2010, 25: 2803-2810. 10.1093/humrep/deq239.View ArticlePubMedPubMed CentralGoogle Scholar
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.